Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone Acetate and Apalutamide (ARN-509) for Rising PSA After Radical Prostatectomy With Adverse Features.(FORMULA-509 Trial)
What is the purpose of this trial?
This research study is comparing two different combinations of androgen deprivation therapy (ADT) used together with radiation as a treatment for rising PSA after radical prostatectomy (prostate cancer).
- Trial withDana-Farber Cancer Institute
- Start Date06/16/2019
- End Date09/29/2020
- Last Updated06/21/2019
- Study HIC#2000023600